Canakinumab: Todo lo que Necesitas Saber sobre este Tratamiento Innovador ¿Qué es Canakinumab y cómo funciona en el tratamiento de enfermedades? El Canakinumab es un anticuerpo monoclonal que actúa como un inhibidor selectivo de la interleucina-1 beta (IL-1β), una citocina proinflamatoria involucrada en diversas... The post…

Canakinumab: Todo lo que Necesitas Saber sobre este Tratamiento Innovador #Canakinumab #TratamientoInnovador #Salud

Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC

#Spartalizumab in combination with platinum-doublet chemotherapy with or without #canakinumab in patients with PD-L1-unselected, metastatic NSCLC scientiasalut.gencat.cat/handle/11351... #ScientiaVH

Another e.g. of how research into #RareDiseases can help us better understand more common ones. #canakinumab may be an expensive way to treat gout, but if the NLRP3 gene is important to other diseases, then more research will take place & it may lead to other therapeutic options.

Hashtag typos. Well done, Stedman. #canakinumab

'Biggest breakthrough since statins': Drug could prevent heart attacks As well as cutting the risk of a heart attack by a quarter, the drugs halved the chances of dying from cancer and protected against gout and arthritis, researchers …

This is an interesting development for #ilaris #canakinumab @NovartisPharma 'Biggest breakthrough since statins'